Oral GLP-1 drugs may quiet the brain's food craving circuit
Reported byScienceDaily ↗·Sourced by Goodlede
NIH-funded research in mice found that oral GLP-1 receptor agonists such as orforglipron and danuglipron reduce pleasure-driven eating by quieting the central amygdala's reward circuit, offering a previously unrecognized mechanism separate from appetite control and potential applications to substance use disorder.
The findings are limited to mouse models.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at ScienceDaily
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Science
Scientists Crack the Code for Making "Impossible" Nanocrystals
SciTechDaily · Verified
Health
Medications Already in Pharmacies May Slow Aging, And Scientists Are Narrowing Them Down
ScienceAlert · Verified
Health
Scientists Create a 'Breathable' Hydrogel Inspired by Human Lungs
ScienceAlert · Verified